Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2015 3
2016 1
2017 2
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
van den Elsen GA, Ahmed AI, Verkes RJ, Kramers C, Feuth T, Rosenberg PB, van der Marck MA, Olde Rikkert MG. van den Elsen GA, et al. Neurology. 2015 Jun 9;84(23):2338-46. doi: 10.1212/WNL.0000000000001675. Epub 2015 May 13. Neurology. 2015. PMID: 25972490 Free PMC article. Clinical Trial.
[Treatment of dementia].
Blom K, van den Elsen GAH, Koek HL, Sanders JB, Kruithof HC, Claassen JAHR. Blom K, et al. Among authors: van den Elsen GAH. Ned Tijdschr Geneeskd. 2017;161:D1851. Ned Tijdschr Geneeskd. 2017. PMID: 28936936 Review. Dutch.
Effects of tetrahydrocannabinol on balance and gait in patients with dementia: A randomised controlled crossover trial.
van den Elsen GA, Tobben L, Ahmed AI, Verkes RJ, Kramers C, Marijnissen RM, Olde Rikkert MG, van der Marck MA. van den Elsen GA, et al. J Psychopharmacol. 2017 Feb;31(2):184-191. doi: 10.1177/0269881116665357. Epub 2016 Sep 27. J Psychopharmacol. 2017. PMID: 27624148 Clinical Trial.
[Medicinal cannabis].
van den Elsen GAH, In 't Hout FEM, de Vries M, Olde Rikkert MGM, Kramers C, Verkes RJ. van den Elsen GAH, et al. Ned Tijdschr Geneeskd. 2019 May 3;163:D3629. Ned Tijdschr Geneeskd. 2019. PMID: 31120212 Dutch.
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia.
Ahmed AI, van den Elsen GA, Colbers A, Kramers C, Burger DM, van der Marck MA, Olde Rikkert MG. Ahmed AI, et al. Among authors: van den Elsen GA. Psychopharmacology (Berl). 2015 Jul;232(14):2587-95. doi: 10.1007/s00213-015-3889-y. Epub 2015 Mar 11. Psychopharmacology (Berl). 2015. PMID: 25752889 Free PMC article. Clinical Trial.
Efficacy and safety of medical cannabinoids in older subjects: a systematic review.
van den Elsen GA, Ahmed AI, Lammers M, Kramers C, Verkes RJ, van der Marck MA, Rikkert MG. van den Elsen GA, et al. Ageing Res Rev. 2014 Mar;14:56-64. doi: 10.1016/j.arr.2014.01.007. Epub 2014 Feb 5. Ageing Res Rev. 2014. PMID: 24509411 Review.
Cannabinoids for pain in dementia: the good, the bad, and the ugly.
Ahmed AI, van den Elsen GA, van der Marck MA, Olde Rikkert MG. Ahmed AI, et al. Among authors: van den Elsen GA. J Am Geriatr Soc. 2014 May;62(5):1001-2. doi: 10.1111/jgs.12817. J Am Geriatr Soc. 2014. PMID: 24828945 No abstract available.
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trial.
Ahmed AI, van den Elsen GA, Colbers A, van der Marck MA, Burger DM, Feuth TB, Rikkert MG, Kramers C. Ahmed AI, et al. Among authors: van den Elsen GA. Eur Neuropsychopharmacol. 2014 Sep;24(9):1475-82. doi: 10.1016/j.euroneuro.2014.06.007. Epub 2014 Jun 28. Eur Neuropsychopharmacol. 2014. PMID: 25035121 Clinical Trial.
Feedback